ZytoDot ® 2C SPEC CDKN2A/CEN 9 Probe

The ZytoDot ® 2C SPEC CDKN2A/CEN 9 Probe is designed for the detection of CDKN2A deletions frequently observed in most tumor cell lines as well as in primary human malignancies. CDKN2A has been identified as a major susceptibility gene for melanoma. The tumor suppressor gene CDKN2A is inactivated by homozygous deletions with high frequency in a variety of human primary tumors e.g. bladder and renal cell carcinoma, non-small cell lung cancer, sarcoma, glioma and mesothelioma. Deletion of the CDKN2A gene is found in up to 80% of T-cell acute lymphoblastic leukemia cases.

Probe Maps


Ordering Information

Prod. No.:Tests¹ (Volume):Registration Status²:
40 (400 μl)

Download Information


1 Using 10 μl probe solution per test.
2 In vitro diagnostic medical device according to EU directive 98/79/EC. 
CE IVD only available in certain countries. All other countries research use only! 
Please contact your local dealer for more information.




ISO 9001
ISO 13485
ZytoVision GmbH


For ZytoVision products additional information is available, which is only valid outside the United States of America (USA). With this action you confirm that you have read this legal notice, that you agree with the terms of use, and that you are not intending to use the information provided on this website within USA.

Accept & Continue